Study showed low repeatability of Macuscope. Comparison with Quantifeye is not agreeable. Macuscope considered to produce unreliable data.
Blue-light filtering IOLs have no clinically substantiated risks and have potential to create the benefits of better vision and reduced glare, and may have a protective effect against retinal phototoxicity and the development and progression of AMD
Measures of central visual function, including best corrected visual acuity (BCVA) and contrast sensitivity, were positively associated with MPOD. Photostress and glare sensitivity were unrelated to MPOD.